Metfogama 850 film-coated tablets 850 mg No. 120

Metfogamma tablets are indicated for:

Composition

Active ingredient: metformin;

1 tablet contains metformin hydrochloride 850 mg;

Excipients: hypromellose, povidone (K 25), magnesium stearate, polyethylene glycol 6000, titanium dioxide (E 171).

Contraindication

Method of application

Usually the initial dose is 500 mg (1/2 tablet of Metfogamma® 1000) 2-3 times a day during or after meals.

After 10-15 days, the dose should be adjusted according to the results of serum glucose measurements.

Slowly increasing the dose helps reduce side effects from the digestive tract.

The maximum recommended dose is 3000 mg per day, divided into 3 doses.

If switching from another antidiabetic agent, it is necessary to discontinue this agent and prescribe metformin as described above.

Application features

Pregnant women

When planning a pregnancy, as well as in the event of pregnancy, it is recommended to use metformin to treat diabetes, and insulin to maintain blood glucose levels as close to normal as possible, to reduce the risk of developing fetal defects.

Children

The drug Metfogamma is used to treat children aged 10 years and older.

Drivers

With caution

Overdose

When using the drug at a dose of 85 g, hypoglycemia was not observed. However, in this case, the development of lactic acidosis was observed. A significant excess of the metformin dose or concomitant risk factors can lead to the occurrence of lactic acidosis. Lactic acidosis is an emergency. In the event of lactic acidosis, treatment with the drug must be discontinued and the patient urgently hospitalized. The most effective measure for removing lactate and metformin from the body is hemodialysis.

Side effects

Nervous system disorders: Common: taste disturbance.

Gastrointestinal tract. Very common: digestive system disorders such as: nausea, vomiting, diarrhea, abdominal pain, lack of appetite. Most often, these side effects occur at the beginning of treatment and in most cases disappear spontaneously. To prevent the occurrence of side effects from the gastrointestinal tract, a slow increase in the dose of the drug is recommended.

Interaction

Alcohol. Acute alcohol intoxication is associated with an increased risk of lactic acidosis, especially in cases of fasting or low-calorie diet, as well as in liver failure. During treatment with Metfogamma, ethanol and ethanol-containing drugs should be avoided.

Combinations that should be used with caution. Drugs that have a hyperglycemic effect (systemic and local corticosteroids, sympathomimetics). It is necessary to monitor the blood glucose level more often, especially at the beginning of treatment. During and after discontinuation of such combined therapy, it is necessary to adjust the dose of Metfogamma under the control of the glycemia level.

Storage conditions

Store at a temperature not exceeding 25ºС.

Keep out of reach of children!

Shelf life - 4 years.